These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 37081671)
1. Establishment of a novel experimental system using single cell-derived pleomorphic rhabdomyosarcoma cell lines expressing K-RasG12V and deficient in p53. Saito H; Suzuki N Exp Anim; 2023 Nov; 72(4):446-453. PubMed ID: 37081671 [TBL] [Abstract][Full Text] [Related]
2. Cooperation of oncogenic K-ras and p53 deficiency in pleomorphic rhabdomyosarcoma development in adult mice. Tsumura H; Yoshida T; Saito H; Imanaka-Yoshida K; Suzuki N Oncogene; 2006 Dec; 25(59):7673-9. PubMed ID: 16785989 [TBL] [Abstract][Full Text] [Related]
3. Pleomorphic rhabdomyosarcoma in adults: a clinicopathologic study of 38 cases with emphasis on morphologic variants and recent skeletal muscle-specific markers. Furlong MA; Mentzel T; Fanburg-Smith JC Mod Pathol; 2001 Jun; 14(6):595-603. PubMed ID: 11406662 [TBL] [Abstract][Full Text] [Related]
4. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma. Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224 [TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic features of pleomorphic rhabdomyosarcoma]. Yu L; Wang J Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431 [TBL] [Abstract][Full Text] [Related]
6. p53 mutation and loss have different effects on tumourigenesis in a novel mouse model of pleomorphic rhabdomyosarcoma. Doyle B; Morton JP; Delaney DW; Ridgway RA; Wilkins JA; Sansom OJ J Pathol; 2010 Oct; 222(2):129-37. PubMed ID: 20662002 [TBL] [Abstract][Full Text] [Related]
7. Complete loss of Beird HC; Wu CC; Nakazawa M; Ingram D; Daniele JR; Lazcano R; Little L; Davies C; Daw NC; Wani K; Wang WL; Song X; Gumbs C; Zhang J; Rubin B; Conley A; Flanagan AM; Lazar AJ; Futreal PA HGG Adv; 2023 Oct; 4(4):100224. PubMed ID: 37593416 [TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of a bladder pleomorphic rhabdomyosarcoma in an adult patient. Feroce F; Cantile M; Aquino G; Collina F; Scognamiglio G; Castaldo L; Perdonà S; Botti G; De Chiara A Pathol Res Pract; 2020 Aug; 216(8):153033. PubMed ID: 32703497 [TBL] [Abstract][Full Text] [Related]
9. Cytogenetic and real-time quantitative reverse-transcriptase polymerase chain reaction analyses in pleomorphic rhabdomyosarcoma. Li G; Ogose A; Kawashima H; Umezu H; Hotta T; Tohyama T; Ariizumi T; Endo N Cancer Genet Cytogenet; 2009 Jul; 192(1):1-9. PubMed ID: 19480930 [TBL] [Abstract][Full Text] [Related]
10. Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice. Ianzano ML; Croci S; Nicoletti G; Palladini A; Landuzzi L; Grosso V; Ranieri D; Dall'Ora M; Santeramo I; Urbini M; De Giovanni C; Lollini PL; Nanni P Oncotarget; 2014 Jan; 5(1):108-19. PubMed ID: 24334679 [TBL] [Abstract][Full Text] [Related]
11. Distinct and overlapping sarcoma subtypes initiated from muscle stem and progenitor cells. Blum JM; Añó L; Li Z; Van Mater D; Bennett BD; Sachdeva M; Lagutina I; Zhang M; Mito JK; Dodd LG; Cardona DM; Dodd RD; Williams N; Ma Y; Lepper C; Linardic CM; Mukherjee S; Grosveld GC; Fan CM; Kirsch DG Cell Rep; 2013 Nov; 5(4):933-40. PubMed ID: 24239359 [TBL] [Abstract][Full Text] [Related]
13. Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma. Slemmons KK; Crose LE; Rudzinski E; Bentley RC; Linardic CM PLoS One; 2015; 10(10):e0140781. PubMed ID: 26496700 [TBL] [Abstract][Full Text] [Related]
14. K-Ras and p53 mouse model with molecular characteristics of human rhabdomyosarcoma and translational applications. Nakahata K; Simons BW; Pozzo E; Shuck R; Kurenbekova L; Prudowsky Z; Dholakia K; Coarfa C; Patel TD; Donehower LA; Yustein JT Dis Model Mech; 2022 Feb; 15(2):. PubMed ID: 35174853 [TBL] [Abstract][Full Text] [Related]
15. Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile. Schleicher S; Grote S; Malenke E; Chan KC; Schaller M; Fehrenbacher B; Riester R; Kluba T; Frauenfeld L; Boesmueller H; Göhring G; Schlegelberger B; Handgretinger R; Kopp HG; Traub F; Boehme KA Cells; 2020 Dec; 9(12):. PubMed ID: 33322555 [TBL] [Abstract][Full Text] [Related]
16. Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice. Nanni P; Nicoletti G; De Giovanni C; Croci S; Astolfi A; Landuzzi L; Di Carlo E; Iezzi M; Musiani P; Lollini PL Cancer Res; 2003 Jun; 63(11):2728-32. PubMed ID: 12782574 [TBL] [Abstract][Full Text] [Related]
17. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Taylor AC; Shu L; Danks MK; Poquette CA; Shetty S; Thayer MJ; Houghton PJ; Harris LC Med Pediatr Oncol; 2000 Aug; 35(2):96-103. PubMed ID: 10918230 [TBL] [Abstract][Full Text] [Related]
18. p53 family members in myogenic differentiation and rhabdomyosarcoma development. Cam H; Griesmann H; Beitzinger M; Hofmann L; Beinoraviciute-Kellner R; Sauer M; Hüttinger-Kirchhof N; Oswald C; Friedl P; Gattenlöhner S; Burek C; Rosenwald A; Stiewe T Cancer Cell; 2006 Oct; 10(4):281-93. PubMed ID: 17045206 [TBL] [Abstract][Full Text] [Related]